Blue Horseshoe Stocks: More Bottom-Plays

Seres Therapeutics, Inc. MCRB 

It was a pretty slow start to the week yesterday with the markets gapping up early, but falling into decline throughout the session. That didn’t stop the one fresh idea we did have in our morning report from posting a respectable performance on the day.

We referred to MCRB as a ‘prime bottom play’ and while it didn’t exactly explode out of the gate, what we did see was certainly a step in the right direction. From a low of 2.63, the stock ran a modest but solid 16% to a high of 3.06. More importantly, it preserved its momentum by holding the three-dollar mark into the close. A good first day by any stretch of the imagination.

We’ll continue to monitor our longer term options idea that we included, the MCRB 07/19 $2.50 Calls which stand to do well in coming weeks if the stock can continue to maintain the current trend. Yesterday’s session was the fourth consecutive day that the stock has recorded higher lows, and we’ll want to see more of that moving forward.


Verastem Inc. VSTM 

Speaking of bottom plays, we’ve got another one to add to our radars this morning in VSTM. This stock has lost a ton of value over the past year, and recently began to show signs of a rebound. We like it for its technical setup and volatility potential. We will remain interested in tracking VSTM for as long as it can maintain support at 1.72 or better.

VSTM is considered by some to be a speculative buyout play as well. Just this week the company has reported positive early stage data on Copiktra, the company’s leukemia treatment under development. Definitely an interesting story to follow.

____

Celestica Inc. CLS

Perhaps even more attractive as a bottom play than the above mentioned stock, we’ve got CLS, which just began to show signs of life after recording a new annual low at the beginning of this month.

If the stock can manage to break its 50DMA at 7.09, there’s a real chance that it could produce significant gains, filling the gap to the topside on the chart. Interesting to naote about CLS as well, is that the company’s EPS has grown by nearly 90% over the past year. When taking that into consideration, its current valuation doesn’t make a whole lot of sense.


Extended Watchlist:
CBAY, DERM, SAVA, NERV, NDRA, PHUN, VIVE

Blue Horseshoe Stocks: GNCA Review & More

OPTIONS REVIEW

We wrapped things up on Friday by going over some of our successes for the week,. and we also provided readers with a couple of quick strike options ideas for Friday’s session itself. It should come as no surprise, given the sheer numbers of winners we routinely unearth, that both of our ideas proved to be excellent chances to finish the week on a very high note.

Here are the ideas along with the total possible gains that could have been achieved on the day.

OKTA Weekly $111-113 Calls
$111 Calls – Range: 2.20-8.62  – Max Gain: 292%
$112 Calls – Range: 1.81-7.69 – Max Gain: 325%
$113 Calls – Range: 1.28-6.20 – Max Gain: 384%

BIG 06/21 $30-32.50 Calls
$30 Calls – Range: .15-.35   – Max Gain: 133%
$32.50 Calls – Range: .05-.15 – Max Gain: 200%
____

SPY OPTIONS:
If the SPY can break 275.27, we’ll be looking at the Weekly $275.50 Calls, and if it falls below 274.50, we’ll be tracking the Weekly $274 Puts.


Genocea Biosciences, Inc. GNCA

We originally began tracking GNCA in our very first report of the new year (01/02) and we wanted to follow up with it now, five months later, as we are very impressed with where the stock has ended up. The stock actually set its 2019 low of 2.50 on January 2nd and it hasn’t looked back since.

By the end of February, the stock had doubled to five dollars, and now, it has doubled again. This morning in premarket trading, we’ve witnessed a new of 12.22 from GNCA, representing an total rise of 388% over our observed low. We’re going to be very interested to see what it’s going to do in this newfound blue-sky territory.


Extended Watchlist:
AMPG, MRTX, CYTR, AIMT, TRVN, APL, HEB, FSM, MYT, IGLD, VSTM, LODE

Blue Horseshoe Stocks: Big Options Success

OPTIONS RECAP:

We had a trio of fresh options ideas which we offered to our readers in yesterday’s premarket report, and with a big day for the markets as a whole, every single idea within our designated ranges produced big gain opportunities on the day.

Twitter, Inc. TWTR Weekly $35.50-37 Calls
$35.50 Calls – Range: 1.72-5.82  – Max Gain: 238%
$36 Calls – Range: 1.52-4.74 – Max Gain: 212%
$36.50 Calls – Range: 1.05-4.05  – Max Gain: 286%
$37 Calls – Range: .90-3.60  – Max Gain: 300%

Hasbro, Inc. HAS Weekly $97-101 Calls
$97 Calls – Range: 4.20-5.75  – Max Gain: 37%
$98 Calls – Range: 3.00-4.80 – Max Gain: 60%
$99 Calls – Range: 2.56-3.50  – Max Gain: 37%
$100 Calls – Range: 1.85-3.60  – Max Gain: 95%
$101 Calls – Range: 1.56-3.10  – Max Gain: 99%

Lockheed Martin Corp. LMT Weekly $327.50-$337.50 Calls
$327.50 Calls – Range: 2.65-10.33  – Max Gain: 290%
$330 Calls – Range: 1.25-8.30 – Max Gain: 564%
$332.50 Calls – Range: 1.10-6.30  – Max Gain: 473%
$335 Calls – Range: .45-4.60  – Max Gain: 922%
$337 Calls – Range: .90-3.30  – Max Gain: 267%
_____

FRESH IDEAS:
Dominos Pizza, Inc. DPZ 05/17 $290-300 Calls
SAP SE (SAP) 05/17 $125-130 Calls

Ebay, Inc. EBAY Weekly $37.50-38.50 Calls


Yuma Energy Inc. YUMA

We also want to circle back for YUMA, which we tagged for observation a week ago today on the 17th. The stock has produced a very solid run in the four sessions since that time.

We have watched as YUMA has run from a low of .151, up to yesterday’s high of .385, which marks a move of 155% on significantly higher volume than the stock is accustomed to seeing.


Extended Watchlist:
CVM, MTP, MANH, CSL, VSTM, TEL, BLIN,